Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News

AI Tools Aid Lung Disease Detection in Autoimmune Diseases

AI-based deep learning models can detect interstitial lung disease from lung ultrasound images in patients with systemic sclerosis and idiopathic inflammatory myopathy.

Extended Antibiotic Use Common in Children With HS

Children with hidradenitis suppurativa often receive antibiotics for about a year before switching to other therapies, a study shows.

Imaging Beats Palpation for Skin Cancer Staging

Ultrasonography and CT beat physical exam for nodal metastasis detection in patients with high-risk skin cancer but show poor sensitivity in immunosuppressed patients.

Laser Pretreatment Boosts Actinic Keratosis Clearance

Ablative fractional laser-assisted daylight photodynamic therapy can achieve higher sustained lesion-specific clearance than daylight photodynamic therapy alone in patients with actinic keratosis.

Regeneron Wins FDA Approval for First Gene Therapy for Genetic Hearing Loss

The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare genetic form of ⁠deafness, the company said on Thursday.

AI Holds Promise in Dermatology, Concerns Remain

The potential benefits and pitfalls of this rapidly evolving technology for dermatologists are debated at AAD 2026.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Latest News

AI-based deep learning models can detect interstitial lung disease from lung ultrasound images in patients with systemic sclerosis and idiopathic inflammatory myopathy.

Children with hidradenitis suppurativa often receive antibiotics for about a year before switching to other therapies, a study shows.

Ultrasonography and CT beat physical exam for nodal metastasis detection in patients with high-risk skin cancer but show poor sensitivity in immunosuppressed patients.

Ablative fractional laser-assisted daylight photodynamic therapy can achieve higher sustained lesion-specific clearance than daylight photodynamic therapy alone in patients with actinic keratosis.

The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare genetic form of ⁠deafness, the company said on Thursday.

The potential benefits and pitfalls of this rapidly evolving technology for dermatologists are debated at AAD 2026.

News All Time

FDA Approves Radiesse Filler for Decolletage Wrinkles

An agency advisory committee in 2025 recommended more study of fillers in that body area to address potential safety concerns.

Insmed Discontinues Development Of Skin Condition Drug After Mid-stage Study Miss

Insmed said on Tuesday it would discontinue the development ⁠of its treatment for a chronic, inflammatory skin condition, after ⁠the drug failed a mid-stage...

Dermocosmetics: Are Therapeutic Cosmetics Real?

From acne to rosacea, growing evidence shows targeted dermocosmetics can serve as monotherapy for mild disease or as adjunctive care, improving outcomes and treatment tolerability.

Cutaneous Appendageal Tumors: Worse Outcomes in Black People

Black patients wait weeks longer for therapy than White patients following diagnosis with rare skin cancer, and on average, deaths occur earlier.

Barriers Disrupt Isotretinoin Access in Underserved Teens

Most underserved teens report barriers to isotretinoin access, a survey found.

Adalimumab and Ixekizumab Show Similar Joint Outcomes in PsA

Adalimumab and ixekizumab show comparable effectiveness in improving joint outcomes and achieving remission in patients with psoriatic arthritis over 12 months, according to a real-world study.

Doxycycline for Acne: Impact on STIs

The lower risk for composite bacterial STI in patients taking doxycycline for acne is driven primarily by reduced risk for chlamydia, according to an analysis of TriNetX data.

India's 'Mounjaro Brides': Weight-loss Injections Become Part Of Pre-wedding Preparation

Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India.

Strength Training Potentially Beneficial in Patients With HS

Development of validated interventions and guidance for physical therapists and dermatologists — and HS patients themselves — is a goal.

Indoor Tanning Linked to Melanoma Diagnosis at Younger Age

Exposure to indoor tanning, especially before age 25, is associated with substantially earlier melanoma diagnosis compared with no exposure.

Topical Probiotics Boost Diabetic Foot Ulcer Healing

Topical probiotics significantly improve healing rates and reduce time to heal in diabetic foot ulcers, compared with placebo, in a study.

CLL Tied to Increased Skin Cancer Risk Over 10 Years

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and death.

Weight-Loss Drug-Biologic Combo Boosts Relief in PsA

ACR50 scores improve when tirzepatide is added to ixekizumab in higher-BMI group, in two trials.

EU Backs Targeted BRAF Combo in Melanoma, Thyroid Cancer

European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.

TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.

Incyte's Skin Disease Drug Shows Long-term Symptom Relief in Late-stage Trials

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in ⁠two late-stage trials.

Recommended News For You

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer

Why alarm is easing over a rise in pancreatic cancer among the young

Mental health risk persists years after cancer diagnosis

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

In early dementia, SSRIs enhance cognition and major depression.

Recommended Articles For You

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v 

Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education 

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring 

First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

After two years, a significant left nasal obstruction was finally diagnosed.

2.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

3.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

4.

AI could help improve early detection of interval breast cancers

5.

Older Adults With Advanced Cancer Prioritize Quality of Life

1.

Managing Hematoma: A Guide to Prevention and Treatment

2.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

3.

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%

4.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

5.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

3.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot